Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.3 HKD | -17.01% |
|
-35.34% | 0.00% |
Jun. 17 | Qyuns Therapeutics Releases Data from Phase 2 Trial for Prurigo Nodularis Drug | MT |
May. 30 | Qyuns Therapeutics Enrolls First Subject in Phase 3 Trial of Skin Disease Drug | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- 2509 Stock
- News Qyuns Therapeutics Co., Ltd.
- Official Publications